Dogs with diet-associated dilated cardiomyopathy have higher urine di-docosahexaenoyl (22:6)-bis(monoacylglycerol)phosphate, a biomarker of phospholipidosis
American Journal of Veterinary Research · 2025
DOI: 10.2460/ajvr.24.07.0211 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Veterinary Research, 2025. Verfasst von Lisa M Freeman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, MA. Hauptthemen laut MEDLINE: Dog Diseases, Biomarkers, Diet, Cardiomyopathy, Dilated. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
OBJECTIVE In dogs with diet-associated dilated cardiomyopathy (DCM), we have identified electron microscopic changes suggestive of abnormal lysosomal accumulation of phospholipids and consistent with the appearance of drug-induced phospholipidosis in people and other animals. The objective of this study was to compare concentrations of urine di-docosahexaenoyl (22:6)-bis(monoacylglycerol)phosphate (BMP), a biomarker of drug-induced phospholipidosis, in dogs with DCM eating high-pulse (HP) diets, dogs with DCM eating low-pulse (LP) diets, and healthy controls (control-HP and control-LP). METHODS In this cross-sectional study, voided urine was collected from client-owned dogs with DCM from September 2018 through March 2020. Urine di-22:6-BMP was measured by LC-MS-MS and normalized to urine creatinine. Normalized di-22:6-BMP concentrations were compared among groups using mixed-effects-model analysis. RESULTS 53 dogs were included: DCM-HP (n = 25), DCM-LP (n = 4), control-HP (n = 10), and control-LP (n = 14). Mixed-effects models adjusted for age and sex showed that HP diet was significantly associated with higher normalized urine di-22:6-BMP concentrations. A 1-way ANOVA identified a significant difference among the 4 groups, with Tukey post hoc analysis showing that the DCM-HP group had significantly higher normalized urine di-22:6-BMP concentrations compared to the control-LP group. Normalized di-22:6-BMP concentrations were significantly positively correlated with diet pulse scores ( r = 0.52). CONCLUSIONS High-pulse diets were significantly associated with higher normalized urine di-22:6-BMP concentrations. CLINICAL RELEVANCE These results support the possible presence of primary or secondary phospholipidosis in dogs with diet-associated DCM and provide a plausible mechanism for further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, MA.
- B2 Pathology Solutions LLC, Cary, NC.
- Department of Pathology, Brigham and Women's Hospital, Harvard Medical School Teaching Hospital, Boston, MA.
- Department of Comparative Pathobiology, Cummings School of Veterinary Medicine, Tufts University, North Grafton, MA.
ORCID-Profile: Lisa M Freeman, John E Rush, Esther Gisela Martinez-Romero
Zitieren
APA
Freeman, L. M., Rush, J. E., Berridge, B. R., Mitchell, R. N., & Martinez-Romero, E. G. (2025). Dogs with diet-associated dilated cardiomyopathy have higher urine di-docosahexaenoyl (22:6)-bis(monoacylglycerol)phosphate, a biomarker of phospholipidosis. American Journal of Veterinary Research. https://doi.org/10.2460/ajvr.24.07.0211
Vancouver
Freeman LM, Rush JE, Berridge BR, Mitchell RN, Martinez-Romero EG. Dogs with diet-associated dilated cardiomyopathy have higher urine di-docosahexaenoyl (22:6)-bis(monoacylglycerol)phosphate, a biomarker of phospholipidosis. American Journal of Veterinary Research. 2025. doi:10.2460/ajvr.24.07.0211
BibTeX
@article{Freeman2025,
author = {Freeman, Lisa M and Rush, John E and Berridge, Brian R and Mitchell, Richard N and Martinez-Romero, Esther Gisela},
title = {Dogs with diet-associated dilated cardiomyopathy have higher urine di-docosahexaenoyl (22:6)-bis(monoacylglycerol)phosphate, a biomarker of phospholipidosis},
journal = {American Journal of Veterinary Research},
year = {2025},
doi = {10.2460/ajvr.24.07.0211}
}
EUVIMED